Polyethyleneimine/poly-(γ-glutamic acid)/poly(lactide-co-glycolide) nanoparticles for loading and releasing antiretroviral drug

Mugavero, 2004, HIV resistance and the effectiveness of combination antiretroviral treatment, Drug Discov. Today Ther. Strateg., 1, 529, 10.1016/j.ddstr.2004.11.006 Kuo, 2007, Transport of stavudine, delavirdine, and saquinavir across the blood–brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles, Int. J. Pharm., 340, 143, 10.1016/j.ijpharm.2007.03.012 Brasnjevic, 2009, Delivery of peptide and protein drugs over the blood–brain barrier, Prog. Neurobiol., 87, 212, 10.1016/j.pneurobio.2008.12.002 Kuo, 2005, Transport of zidovudine- and lamivudine-loaded polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate nanoparticles across the in vitro blood–brain barrier: characteristics of the drug-delivery system, J. Chin. Inst. Chem. Eng., 36, 627 Vorbrodt, 1989, Ultracytochemical characterization of anionic sites in the wall of brain capillaries, J. Neurocytol., 18, 359, 10.1007/BF01190839 Béduneau, 2007, Active targeting of brain tumors using nanocarriers, Biomaterials, 28, 4947, 10.1016/j.biomaterials.2007.06.011 Gabathuler, 2010, Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases, Neurobiol. Dis., 37, 48, 10.1016/j.nbd.2009.07.028 Tsuji, 1999, Carrier-mediated or specialized transport of drugs across the blood–brain barrier, Adv. Drug Deliv. Rev., 36, 277, 10.1016/S0169-409X(98)00084-2 Abbott, 2004, Prediction of blood–brain barrier permeation in drug discovery from in vivo, in vitro and in silico models, Drug Discov. Today Technol., 1, 407, 10.1016/j.ddtec.2004.11.014 Abbott, 2010, Structure and function of the blood–brain barrier, Neurobiol. Dis., 37, 13, 10.1016/j.nbd.2009.07.030 Y.C. Kuo, P.I. Lin, C.C. Wang, Targeting nevirapine delivery across human brain microvesscular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles, Nanomedicine, in press, doi:10.2217/nnm.11.25. Shih, 2001, The production of poly(γ-glutamic acid) from microorganisms and its various applications, Bioresour. Technol., 79, 207, 10.1016/S0960-8524(01)00074-8 Akagi, 2005, Preparation and characterization of biodegradable nanoparticles based on poly(g-glutamic acid) with l-phenylalanine as a protein carrier, J. Control. Release, 108, 226, 10.1016/j.jconrel.2005.08.003 Yoshikawa, 2008, Nanoparticles built by self-assembly of amphiphilic γ-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effector T cells, Vaccine, 26, 1303, 10.1016/j.vaccine.2007.12.037 Okamoto, 2009, Poly(glutamic acid) nanoparticles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice, Vaccine, 27, 5896, 10.1016/j.vaccine.2009.07.037 Peng, 2009, Effects of incorporation of poly(γ-glutamic acid) in chitosan/DNA complex nanoparticles on cellular uptake and transfection efficiency, Biomaterials, 30, 1797, 10.1016/j.biomaterials.2008.12.019 Markland, 1999, Modified polypeptides containing γ-benzyl glutamic acid as drug delivery platforms, Int. J. Pharm., 178, 183, 10.1016/S0378-5173(98)00373-1 Vancha, 2004, Use of polyethyleneimine polymer in cell culture as attachment factor and lipofection enhancer, BMC Biotechnol., 4, 23, 10.1186/1472-6750-4-23 Bledi, 2004, Culturing neuronal cells on surfaces coated by a novel polyethyleneimine-based polymer, Brain Res. Protoc., 20, 1797 Lakard, 2004, Adhesion and proliferation of cells on new polymers modified biomaterials, Bioelectrochemistry, 62, 19, 10.1016/j.bioelechem.2003.09.009 Kuo, 2009, Application of polyethyleneimine-modified scaffolds to the regeneration of cartilaginous tissue, Biotechnol. Prog., 25, 1459, 10.1002/btpr.232 Yallapu, 2011, Design and engineering of nanogels for cancer treatment, Drug Discov. Today, 16, 457, 10.1016/j.drudis.2011.03.004 Kreuter, 2005, Application of nanoparticles for the delivery of drugs to the brain, Int. Congr. Ser., 1277, 85, 10.1016/j.ics.2005.02.014 Kuo, 2010, Effect of electromagnetic field on endocytosis of cationic solid lipid nanoparticles by human brain-microvascular endothelial cells, J. Drug Target., 18, 447, 10.3109/10611860903494245 Acharya, 2011, PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect, Adv. Drug Deliv. Rev., 63, 170, 10.1016/j.addr.2010.10.008 Kuo, 2011, Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells, Colloids Surf. B, 85, 131, 10.1016/j.colsurfb.2011.02.011 Li, 2002, Poly(l-glutamic acid)–anticancer drug conjugates, Adv. Drug Deliv. Rev., 54, 695, 10.1016/S0169-409X(02)00045-5 Berry, 1967, Thermodynamic and conformational properties of polystyrene. II. Intrinsic viscosity studies on dilute solutions of linear polystyrenes, J. Phys. Chem., 46, 1338, 10.1063/1.1840854 Togrul, 2003, Flow properties of sugar beet pulp cellulose and intrinsic viscosity–molecular weight relationship, Carbohydr. Polym., 54, 63, 10.1016/S0144-8617(03)00146-2 Kuo, 2005, Loading efficiency of stavudine on polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate copolymer nanoparticles, Int. J. Pharm., 290, 161, 10.1016/j.ijpharm.2004.11.025 Kuo, 2009, Differentiation of bone marrow stromal cells in poly(lactide-co-glycolide)/chitosan scaffolds, Biomaterials, 30, 6604, 10.1016/j.biomaterials.2009.08.028 Kuo, 2011, Surface coverage of didecyl dimethylammonium bromide on poly(lactide-co-glycolide) nanoparticles, Colloids Surf. B, 84, 253, 10.1016/j.colsurfb.2011.01.009 Kuo, 2011, Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers, Colloids Surf. B, 83, 299, 10.1016/j.colsurfb.2010.11.037 Makino, 1994, Surface structure of latex particles covered with temperature-sensitive hydrogel layers, J. Colloid Interface Sci., 166, 251, 10.1006/jcis.1994.1291 Kuo, 2008, Effect of glutamate on the electrical properties of cationic solid lipid nanoparticles containing stearylamine and dioctadecyldimethyl ammonium bromide, J. Phys. Chem. B, 112, 4454, 10.1021/jp711420g Kuo, 2011, Inverted colloidal crystal scaffolds with laminin-derived peptides for neuronal differentiation of bone marrow stromal cells, Biomaterials, 32, 819, 10.1016/j.biomaterials.2010.09.057 Kuo, 2009, Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles, Int. J. Pharm., 365, 206 Kuo, 2010, Electrophoresis of human brain microvascular endothelial cells with uptake of cationic solid lipid nanoparticles: effect of surfactant composition, Colloids Surf. B, 76, 286, 10.1016/j.colsurfb.2009.11.006 Kuo, 2005, Deposition of cation-absorptive biocolloids onto a charged surface, J. Colloid Interface Sci., 288, 36, 10.1016/j.jcis.2005.02.087 Kuo, 2011, Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor, Biomaterials, 32, 3340, 10.1016/j.biomaterials.2011.01.048 Zolnik, 2006, Elevated temperature accelerated release testing of PLGA microspheres, J. Control. Release, 112, 293, 10.1016/j.jconrel.2006.02.015 Faisant, 2006, Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory, Int. J. Pharm., 314, 189, 10.1016/j.ijpharm.2005.07.030